Ticker Details
Erasca, Inc.
IPO Date:	July 16, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$4.37B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.26 | 4.20%
Avg Daily Range (30 D):	$0.50 | 4.42%
Avg Daily Range (90 D):	$0.70 | 4.83%

Institutional Daily Volume
Avg Daily Volume:	1.4M
Avg Daily Volume (30 D):	4.7M
Avg Daily Volume (90 D):	5.36M

Trade Size
Avg Trade Size (Sh.):	134
Avg Trade Size (Sh.) (30 D):	104
Avg Trade Size (Sh.) (90 D):	108

Institutional Trades
Total Institutional Trades:	1,175
Avg Institutional Trade:	$2.2M
Avg Institutional Trade (30 D):	$2.2M
Avg Institutional Trade (90 D):	$2.54M
Avg Institutional Trade Volume:	.28M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$4.39M
Avg Closing Trade (30 D):	$5.47M
Avg Closing Trade (90 D):	$7.95M
Avg Closing Volume:	550.7K

News

Jun 12, 2026 @ 5:50 PM ROSEN, LEADING INVESTOR RIGHTS COUNSEL, Encourages... Source: Rosen Law Firm

Jun 11, 2026 @ 9:54 PM Bragar Eagel & Squire, P.C. Announces that a Class... Source: Bragar Eagel & Squire, P.C.

Jun 11, 2026 @ 12:17 AM ADMA LAWSUIT: ADMA Biologics, Inc. Sued For Securi... Source: Block & Leviton Llp

Jun 10, 2026 @ 8:56 PM SHAREHOLDER ALERT: Erasca, Inc. Sued For Securitie... Source: Block & Leviton Llp

May 30, 2026 @ 12:27 AM Why This Fund Made a $189 Million Bet on Erasca as... Source: Jonathan Ponciano

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.93	$-.6	$-.1
Diluted EPS	$-.93	$-.6	$-.1
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-277.02M	$-183.44M	$-29.09M
Operating Income / Loss	$-293.19M	$-187.91M	$-32.6M
Cost of Revenue
Net Cash Flow	$-23.23M	$-26.55M	$3.58M
PE Ratio